Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease.

MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes.

Axial Therapeutics is a biopharmaceutical company targeting neurological disorders such as Parkinson's and Autism via gut health.

Convalesce is a company developing a stem cell based therapy for neurological conditions that leads to degeneration of neurons, like Parkinson's.

Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.

Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases

Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.

A biopharmaceutical company that develops therapies to treat Autism, neurological and other disorders

OccamzRazor is an artificial Intelligence company founded in 2015 by Katharina Sophia Volz.

Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases

Novel positive allosteric modulators of the metabotropic glutamate receptor subtype 4

MentiNova's primary strategy is to use L-DOPA, the drug that is currently clinically approved for another indication and repurpose it for the treatment of L-Dopa Induced Dyskinesia in patients with Parkinson's disease.

Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders.